Literature DB >> 21415088

Application of AD8 questionnaire to screen very mild dementia in Taiwanese.

Yuan-Han Yang1, James E Galvin, John C Morris, Chiou-Lian Lai, Mei-Chuan Chou, Ching-Kuan Liu.   

Abstract

The AD8 questionnaire developed by Washington University in St Louis is a screening tool with 8 questions to reliably differentiate nondemented from demented individuals even at the very mild stage. We recruited 239 participants, including 114 cognitively normal, 73 very mild dementia, and 52 mild dementia to validate its application in Taiwanese. The cut-off value of AD8 was 2 in discriminating cognitively normal from demented individuals with the area under curve (AUC) = 0.961, sensitivity = 97.6%, specificity = 78.1%, positive likelihood ratio (PLR) = 4.5, and negative likelihood ratio (NLR) = 0.03. The cut-off value also was 2 in discriminating nondemented from very mild dementia with the AUC = 0.948, sensitivity = 95.9%, specificity = 78.1%, PLR = 4.4, and NLR = 0.05. The Chinese AD8 is effective in discriminating individuals with dementia, even at its mildest stages from those without dementia with properties identical to the original English version. The cAD8 is a quick dementia screening tool that can be applied across cultures.

Entities:  

Mesh:

Year:  2011        PMID: 21415088     DOI: 10.1177/1533317510397330

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  19 in total

1.  Assessing the diagnostic accuracy (DA) of the Spanish version of the informant-based AD8 questionnaire.

Authors:  C Carnero Pardo; R de la Vega Cotarelo; S López Alcalde; C Martos Aparicio; R Vílchez Carrillo; E Mora Gavilán; J E Galvin
Journal:  Neurologia       Date:  2012-05-30       Impact factor: 3.109

2.  Functional Connectivity Dynamics Altered of the Resting Brain in Subjective Cognitive Decline.

Authors:  Yi-Chia Wei; Yi-Chia Kung; Wen-Yi Huang; Chemin Lin; Yao-Liang Chen; Chih-Ken Chen; Yu-Chiau Shyu; Ching-Po Lin
Journal:  Front Aging Neurosci       Date:  2022-06-24       Impact factor: 5.702

3.  AD-8 for detection of dementia across a variety of healthcare settings.

Authors:  Kirsty Hendry; Claire Green; Rupert McShane; Anna H Noel-Storr; David J Stott; Sumayya Anwer; Alex J Sutton; Jennifer K Burton; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2019-03-04

4.  Effect of music intervention on the cognitive and depression status of senior apartment residents in Taiwan.

Authors:  Shu-Yu Tai; Ling-Chun Wang; Yuan-Han Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-06-12       Impact factor: 2.570

5.  A community-based walk-in screening of depression in Taiwan.

Authors:  Shu-Yu Tai; Tzu-Chiao Ma; Ling-Chun Wang; Yuan-Han Yang
Journal:  ScientificWorldJournal       Date:  2014-07-15

6.  Screening dementia in the outpatient department: patients at risk for dementia.

Authors:  Shu-Yu Tai; Shu-Wan Huang; Chia-Ling Hsu; Chiu-Hsien Yang; Mei-Chuan Chou; Yuan-Han Yang
Journal:  ScientificWorldJournal       Date:  2014-12-08

7.  Utility of AD8 for cognitive impairment in a Chinese physical examination population: a preliminary study.

Authors:  Yue Xie; Ya Gao; Jianjun Jia; Xiaohong Wang; Zhenfu Wang; Hengge Xie
Journal:  ScientificWorldJournal       Date:  2014-11-10

8.  A walk-in screening of dementia in the general population in Taiwan.

Authors:  Chun-Hung Chen; Ling-Chun Wang; Tzu-Chiao Ma; Yuan-Han Yang
Journal:  ScientificWorldJournal       Date:  2014-05-04

9.  Current status of sleep quality in Taiwan: a nationwide walk-in survey.

Authors:  Shu-Yu Tai; Wen-Fu Wang; Yuan-Han Yang
Journal:  Ann Gen Psychiatry       Date:  2015-11-02       Impact factor: 3.455

10.  Development and validation of a dementia screening tool for primary care in Taiwan: Brain Health Test.

Authors:  Ping-Huang Tsai; Jian-Liang Liu; Ker-Neng Lin; Chiung-Chih Chang; Ming-Chyi Pai; Wen-Fu Wang; Jen-Ping Huang; Tzung-Jeng Hwang; Pei-Ning Wang
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.